Our results showed that high mRNA levels of MSH6, MLH1, and PMS2 were associated with a favorable OS in ovarian cancer, suggesting these MMR genes may serve as potential positive prognostic indicators in ovarian cancer patients treated with platinum-based chemotherapy. Here, MLH1 is linked to ovarian carcinoma.